Altasciences Drives Inspection Readiness and Sponsor Oversight with eTMF Connect
Altasciences adopts eTMF Connect to improve compliance and oversight across early-phase clinical studies. Moving from a paper-based TMF process into an electronic system will allow Altasciences teams to benefit from real-time reporting features. Sponsors have the same real-time access externally to their documentation allowing direct oversight of the TMF without the need for manual requests.
Read more here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Talvey Plus Tecvayli Shows Promising Results in Multiple Myeloma but Raises Infection Concerns
January 9th 2025A Phase Ib/II dose escalation and expansion trial shows promising antitumor activity and durable responses with Talvey (talquetamab) plus Tecvayli (teclistamab) in the treatment of relapsed or refractory multiple myeloma, but a higher incidence of grade 3 or 4 infections.
